|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08037 CH BIOTECH SER
Nominal 
0.440 0.000 (0.000%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Turnover | 32,449 | -82.206% | 182,357 | 686,909 | 374,159 | 31,305 |
| Cost of Sales | (35,556) | -70.622% | (121,031) | (332,005) | (157,601) | (21,867) |
| Gross Profit | (3,107) | -- | 61,326 | 354,904 | 216,558 | 9,438 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 3,016 | -79.696% | 14,854 | 2,690 | (1,311) | (417) | |
| Profit / (Loss) on Disposal | -- | -- | -- | 1,696 | (507) | -- | |
| Other Non-operating Items | -- | -- | (26) | (1,527) | (2,687) | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (2,771) | (1,032) | 0 | 0 | |
| Profit / (Loss) before Taxation | (126,258) | 411.642% | (24,677) | 253,756 | 138,703 | (46,382) | |
| Taxation | 527 | -- | (3,044) | (47,396) | (29,713) | 603 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 45,814 | -- | (2,763) | (138,140) | (84,751) | 5,511 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (79,917) | 162.160% | (30,484) | 68,220 | 24,239 | (40,268) | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Net Finance Costs / (Income) | 4,245 | 313.743% | 1,026 | 2,294 | 4,071 | 1,862 |
| Depreciation & Amortisation | 12,904 | -63.492% | 35,346 | 33,341 | 33,986 | 11,054 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | -8.300 | 159.375% | -3.200 | 7.100 | 2.500 | -4.200 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.405 | -- | 0.565 | 0.443 | 0.387 | 0.262 |
| Remarks: | Real time quote last updated: 26/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -79,917,000 |
| %Change | 162.160% |
| EPS / (LPS) | HKD -0.083 |
| NBV Per Share ($) | HKD 0.405 |